Table 3.

Relationship of symptomatic groups to treatment, demographic and personal informationResults from multivariable partial proportional odds model with ordinal symptomatic group outcome. Covariates with proportional odds, in the same model as in Table 4.

Covariate	Level	Common odds ratio and 95% C.I.
Gender	Male	1.0
	Female	1.19 (1.05 – 1.34)*
Race	White non-Hispanic	1.0
	Other race	1.10 (0.93 – 1.30)
Age at interview	18–29	1.0
	30–39	1.15 (0.97 – 1.36)
	40+	1.03 (0.81 – 1.30)
Age at dx 0–4: Education	College graduate	1.0
	High school	1.55 (1.19 – 2.03)*
	Some college	1.01 (0.81 – 1.25)
Age at dx 5–9: Education	College graduate	1.0
	High school	1.12 (0.79 – 1.57)
	Some college	1.04 (0.81 – 1.35)
Age at dx 10–14: Education	College graduate	1.0
	High school	1.01 (0.70 – 1.47)
	Some college	1.61 (1.25 – 2.07)*
Age at dx 15–20: Education	College graduate	1.0
	High school	1.05 (0.70 – 1.58)
	Some college	1.17 (0.89 – 1.54)
Chemotherapy	None	1.0
	Anthracycline/alkylating	1.25 (1.08 – 1.45)*
	Other chemo	1.34 (1.11 – 1.62)*
Age at dx 0–4: Radiation	None	1.0
	CRT	2.10 (1.68 – 2.63)**
	Other RT	1.42 (1.11 – 1.82)*
Age at dx 5–9: Radiation	None	1.0
	CRT	1.12 (0.85 – 1.49)
	Other RT	1.29 (0.95 – 1.74)
Age at dx 10–14: Radiation	None	1.0
	CRT	0.92 (0.69 – 1.24)
	Other RT	1.07 (0.81 – 1.41)
Age at dx 15–20: Radiation	None	1.0
	CRT	0.88 (0.60 – 1.29)
	Other RT	0.92 (0.69 – 1.22)
Personal Income	$40K+	1.0
	<$20,000	1.41 (1.19 – 1.67)**
	$20K–$39K	1.05 (0.90 – 1.24)
Recurrence	No	1.0
	Yes	1.29 (1.08 – 1.54)*
SMN	No	1.0
	Yes	1.21 (1.00 – 1.46)

Model adjusted for all variables shown above.

P-values:

^*<.01,

^**<.001